CCL18 and neoplasm: TAMs, abundant components in the TME, release several cytokines and chemokines like IL‐6, CCL18, and IL‐8 for interacting with their respective receptors on cancer cells, thus activating oncogenic pathways and inducing tumor malignancy.36, 37, 38